Abstract
Background
Prevalence and incidence of atrial fibrillation (AF) are high in hemodialysis (HD) patients. Intra-atrial conduction velocity slowing plays an important role in AF onset. The aim of our study was to measure P wave duration (Pwd), expression of intra-atrial conduction velocity, in HD patients with and without a history of AF.
Methods
The study was performed in 47 end stage renal disease (ESRD) patients, subdivided into four groups: 19 patients within the first 6 months from starting HD therapy (HD1); the same patients studied 18 ± 3 months later (HD2); patients with no history of AF and long dialytic age (HD3, n = 13); and patients with sinus rhythm but history of AF (HDAF, n = 15); and 18 healthy controls. In all patients P wave high resolution recording and electrolyte plasma values were obtained before and after a HD session, and atrial diameter was assessed by echocardiography.
Results
Patients with the shortest dialysis vintage showed the shortest Pwd [131.2 ± 11.0 (HD1) vs. 139.8 ± 11.7 (HD2), 142.1 ± 7.2 (HD3), 152.3 ± 15.0 (HDAF) ms; p < 0.05], while Pwd was prolonged in patients with AF history when compared to all other groups (p < 0.03). At multivariate analysis atrial dimension was independently related to Pwd (R = 0.40, p < 0.02). HD session induced a significant increase of Pwd (141 ± 14.0–152 ± 17.0 ms, p < 0.001), that was correlated to modifications of K+ concentration (R = 0.8, p < 0.0001).
Conclusions
HD therapy prolongs Pwd. HD patients with a history of AF have prolonged Pwd compared to patients without, suggesting that increased Pwd is a marker of AF risk in patients with ESRD. HD session acutely increases Pwd, creating conditions favoring AF onset.
Similar content being viewed by others
Referencees
Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D’Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110:1042–1046
Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114(2):119–125
Colman MA, Aslanidi OV, Kharche S, Boyett MR, Garratt CJ, Hancox JC, Zhang H (2013) Pro-arrhythmogenic effects of atrial fibrillation induced electrical remodeling-insights from 3D virtual human atria. J Physiol 591:4249–4272
van Brakel TJ, van der Krieken T, Westra SW, van der Laak JA, Smeets JL, van Swieten HA (2013) Fibrosis and electrophysiological characteristics of the atrial appendage in patients with atrial fibrillation and structural heart disease. J Interv Card Electrophysiol 38:85–93
Fujita M, Cheng XW, Inden Y, Shimano M, Yoshida N, Inoue A, Yamamoto T, Takeshita K, Kyo S, Taguchi N, Shi GP, Kuzuya M, Okumura K, Murohara T (2013) Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker. J Am Heart Assoc. doi:10.1161/JAHA.113.000503
Ball J, Carrington MJ, McMurray JJ, Stewart S (2013) Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol 167:1807–1824
Guijian L, Jinchuan Y, Rongzeng D, Jun Q, Jun W, Wenqing Z (2013) Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies. Pacing Clin Electrophysiol 36:748–756
Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844
Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer D (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375
Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S (2011) The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 22:349–357
Goldstein BA, Arce CM, Hlatky MA, Turakhia M, Setoguchi S, Winkelmayer WC (2012) Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation 126:2293–2301
Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM (2012) Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant 27:3816–3822
Genovesi S, Pogliani D, Faini A, Valsecchi MG, Riva A, Stefani F, Acquistapace I, Stella A, Bonforte G, DeVecchi A, DeCristofaro V, Buccianti G, Vincenti A (2005) Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 46:897–902
Genovesi S, Vincenti A, Rossi E, Pogliani D, Acquistapace I, Stella A, Valsecchi MG (2008) Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 51:255–262
Zhang BC, Che WL, Li WM, Xu YW (2011) Meta-analysis of P wave character as predictor of atrial fibrillation after coronary artery bypass grafting. Int J Cardiol 152:260–262
Steinberg JS, Zelenkofske S, Wong SC, Gelernt M, Sciacca R, Menchavez E (1993) Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation 88:2618–2622
Ciçek D, Camsari A, Pekdemir H, Kiykim A, Akkuş N, Sezer K, Diker E (2003) Predictive value of P-wave signal-averaged electrocardiogram for atrial fibrillation in acute myocardial infarction. Ann Noninvasive Electrocardiol 8:233–237
Aytemir K, Aksoyek S, Yildirir A, Ozer N, Oto A (1999) Prediction of atrial fibrillation recurrence after cardioversion by P wave signal-averaged electrocardiography. Int J Cardiol 70:15–21
Severi S, Pogliani D, Fantini G, Fabbrini P, Viganò MR, Galbiati E, Bonforte G, Vincenti A, Stella A, Genovesi S (2010) Alterations of atrial electrophysiology induced by electrolyte variations: combined computational and P-wave analysis. Europace 12:842–849
Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography, Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463
Stafford P, Denbigh P, Vincent R (1995) Frequency analysis of the P wave: comparative techniques. Pacing Clin Electrophysiol 18:261–270
Dilaveris P, Stefanadis C (2009) Current morphologic and vectorial aspects of P-wave analysis. J Electrocardiol 42:395–399
Krueger MW, Severi S, Rhode K, Genovesi S, Weber FM, Vincenti A, Fabbrini P, Seemann G, Razavi R, Dössel O (2011) Alterations of atrial electrophysiology related to hemodialysis session: insights from a multiscale computer model. J Electrocardiol 44:176–183
Buiten MS, de Bie MK, Rotmans JI, Gabreëls BA, van Dorp W, Wolterbeek R, Trines SA, Schalij MJ, Jukema JW, Rabelink TJ, van Erven L (2014) The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients. Heart 100(9):685–6890
Iwasaki YK, Nishida K, Kato T, Nattel S (2011) Atrial Fibrillation Pathophysiology: implications for Management. Circulation 124:2264–2274
Longobardo L, Todaro MC, Zito C, Piccione MC, Di Bella G, Oreto L, Khandheria BK, Carerj S (2014) Role of imaging in assessment of atrial fibrosis in patients with atrial fibrillation: state-of-the-art review. Eur Heart J Cardiovasc Imaging 15:1–5
Vincenti A, Passini E, Fabbrini P, Luise MC, Severi S, Genovesi S (2014) Recurrent intradialytic paroxysmal atrial fibrillation: hypotheses on onset mechanism based on clinical data and computational analysis. Europace 16:396–404
Conflict of interest
On behalf of all authors, the corresponding author declares that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Genovesi, S., Fabbrini, P., Pieruzzi, F. et al. Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension. J Nephrol 28, 615–621 (2015). https://doi.org/10.1007/s40620-014-0131-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-014-0131-7